Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/19/11 → 7/19/14 |
Funding
- PRA Health Sciences (Prot # GS-US-256-0148)
- Gilead Sciences, Inc. (Prot # GS-US-256-0148)
Prot # GS-US-256-0148: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy with GS-5885 Alone or in Combination with GS-9451 with Peginterferon Alfa 2a and Ribavin in Treatment Nave Subjects with Chronic Genot
- Flamm, Steven L (PD/PI)
- Ganger, Daniel R (Co-Investigator)
Project: Research project